{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T07:25:42Z","timestamp":1769239542425,"version":"3.49.0"},"reference-count":13,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2009,2,2]],"date-time":"2009-02-02T00:00:00Z","timestamp":1233532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Deutsche Derma Gesell"],"published-print":{"date-parts":[[2009,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>A woman with oculocutaneous Beh\u00e7et disease developed primary tuberculosis while being treated with infliximab. A latent tuberculosis infection had been excluded before therapy. After more than 80 weeks of treatment, the patient complained of fevers, night sweats, shivering and vigorous cough. The chest x\u2010ray showed miliary shadowing. <jats:italic>Mycobacterium tuberculosis<\/jats:italic> was identified. The history revealed recent contact to an individual with smear\u2010positive tuberculosis. This constellation speaks in favor of a de novo tuberculosis infection with a fulminant course.<\/jats:p>","DOI":"10.1111\/j.1610-0387.2009.07040.x","type":"journal-article","created":{"date-parts":[[2009,2,2]],"date-time":"2009-02-02T15:24:19Z","timestamp":1233588259000},"page":"616-618","source":"Crossref","is-referenced-by-count":4,"title":["De novo tuberculosis during infliximab therapy in a patient with Beh\u00e7et disease"],"prefix":"10.1111","volume":"7","author":[{"given":"Hans","family":"Skvara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaus","family":"Duschek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz","family":"Karlhofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,7,3]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh567"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2007.06319.x"},{"key":"e_1_2_6_4_2","first-page":"217","article-title":"Miliary tuberculosis following infliximab therapy for Crohn disease: A case report and review of the literature","volume":"69","author":"Stas P","year":"2006","journal-title":"Acta Gastroenterol Belg"},{"key":"e_1_2_6_5_2","article-title":"Long\u2010Term Safety of Infliximab for the treatment of Inflammatory Bowel Disease: A Single Center Cohort Study","author":"Fidder HH","year":"2008","journal-title":"Gut"},{"key":"e_1_2_6_6_2","article-title":"Risk factors for opportunistic infections in infliximab\u2010treated patients: the importance of screening in prevention","author":"Garcia\u2010Vidal C","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011110"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(08)70227-5"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1086\/593174"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.03.023"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03553.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-007-0558-z"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000191923.08938.5b"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-7-56"}],"container-title":["JDDG: Journal der Deutschen Dermatologischen Gesellschaft"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1610-0387.2009.07040.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1610-0387.2009.07040.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T04:18:54Z","timestamp":1697429934000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1610-0387.2009.07040.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":13,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["10.1111\/j.1610-0387.2009.07040.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1610-0387.2009.07040.x","archive":["Portico"],"relation":{},"ISSN":["1610-0379","1610-0387"],"issn-type":[{"value":"1610-0379","type":"print"},{"value":"1610-0387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}